YSOPIA BIOSCIENCES

YSOPIA

Pharmaceutical and dietetic products, namely, biotherapies comprising cells for medical or clinical use; medicines for use in treating cardiometabolic risk factors, cardiovascular diseases, obesity, pre-diabetes, type-2 diabetes, hepatic steatosis, metabolic diseases, inflammatory diseases, chronic inflammatory bowel diseases, dysbiosis, dysbiosis of the intestinal microbiota; medicines for prevention and treatment of cardiometabolic risk factors, cardiovascular diseases, obesity, pre-diabetes, type-2 diabetes, hepatic steatosis, metabolic diseases, inflammatory diseases, chronic inflammatory bowel diseases, dysbiosis, dysbiosis of the intestinal microbiota; dietetic preparations for medical use; dietetic preparations and food supplements for medical purposes; probiotic supplements; probiotic bacterial preparations for medical use; dietetic drinks and foods for medicinal use;Medical, biological, chemical, dietetic and pharmaceutical research services; medical, biological, chemical, dietetic and pharmaceutical research services on the human microbiome and intestinal microbiota; laboratory analysis and research services in the medical, biological, chemical, dietetic and pharmaceutical fields; research and development of new products for third parties in the medical, biological, dietetic and pharmaceutical fields; provision of information and advice on scientific research in the medical, chemical, biological, dietetic and pharmaceutical fields; provision of scientific research information concerning the results of clinical trials of medical, dietetic, and pharmaceutical products;